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Anterior Pituitary Progenitor Cells Express Costimulatory
Molecule 4Ig-B7-H31
Yasuhiro Nagai,* Hisashi Aso,2* Hideki Ogasawara,* Sachi Tanaka,* Yoshikazu Taketa,*
Kouichi Watanabe,* Shyuichi Ohwada,* Michael T. Rose,† Haruki Kitazawa,‡
and Takahiro Yamaguchi*
Stem/Progenitor cells in the postnatal pituitary gland are embedded in a marginal cell layer around Rathke’s pouch. However, the
nature and behavior of anterior pituitary progenitor cells remain unclear. We established bovine anterior pituitary progenitor cell
line (BAPC)-1 from the anterior pituitary gland, which expressed stem/progenitor cell-related genes and several inflammatory
cytokines. To characterize and localize these pituitary progenitor cells, we produced a mAb (12B mAb) against BAPC-1. The 12B
mAb recognized the 4Ig-B7-H3 molecule, which is a costimulatory molecule and negative regulator in T cell activation. WC1 
T cells in young bovine PBMC express the 4Ig-B7-H3 molecule, but few or no 4Ig-B7-H3-immunoreactive cells are expressed in
PBMC in adult cattle. The 12B-immunoreactive cells in the bovine anterior pituitary gland were localized around Rathke’s pouch
and expressed IL-18 and MHC class II. However, the number of 12B-immunoreactive cells was lower in adult than in young cattle.
BAPC-1 expressed IL-18 and MHC class II, and demonstrated phagocytotic activity. BAPC-1 also had the ability to promote CD25
expression in PBMC after 5 days of coculture, and blocking 4Ig-B7-H3  12B mAb enhanced their expression of CD25. In
addition, the 12B-immunoreactive cells were observed around the pars tuberalis closely bordering the median eminence and in the
blood vessels of the primary portal plexus in the anterior pituitary gland. These results suggest that an established BAPC-1 may
originate from these progenitor cells, and that the progenitor cells with 4Ig-B7-H3 may play a critical role in the immunoendocrine
network. The Journal of Immunology, 2008, 181: 6073–6081.
I t is well known that pituitary function is regulated by thehypothalamic-pituitary-adrenal axis. Recent studies showthat several cytokines, such as IL-1, IL-6, IL-11, IL-18, mac-
rophage-migration inhibitory factor, and leukemia inhibitory fac-
tor, and their specific receptors are expressed in the anterior pitu-
itary gland and play an important role in the neuroendocrine
system by autocrine or paracrine pathways as immune-endocrine
mediators (1–5). It has also been reported that neural multipotent
precursor cells act as immunomodulators during inflammation of
the CNS, which promotes long-lasting neuroprotection (6), and
that the marginal cell layer around Rathke’s pouch has been pro-
posed to contain a stem/progenitor cell compartment in the post-
natal pituitary (7, 8).
Cells in the marginal cell layer of Rathke’s pouch in the anterior
pituitary gland express stem/progenitor molecules. One of them is
Nestin, a class VI intermediate filament protein, whereas the others
are Notch, Wnt, and the sonic hedgehog signaling factors (7,
9–11). We have reported that constituent cells of the marginal cell
layer of Rathke’s pouch in the bovine and porcine pituitary ex-
pressed IL-18 (12, 13). IL-18 is a pleiotropic cytokine, which can
trigger the cytokine signaling pathway and initiate a cytokine cas-
cade immune responses (14). Our previous studies show that IL-18
and its receptor (IL-18R) are expressed in specific cell types of the
bovine and porcine anterior pituitary, and that there are substantial
differences in the distribution of IL-18 and IL-18R between cattle
and pigs (3, 4). These data suggest that IL-18 may be an immu-
noendocrine mediator both through autocrine and paracrine path-
ways. Recently, it has been revealed that the corticotrophs of the
rat anterior pituitary gland express IL-18 (1), and that IL-18 in-
duces the expression of IL-1 and pro-IL-1, and also the release
of IL-6 from mixed glia in vitro (15). In addition, IL-18 has a role
in the homeostasis of energy intake as well as insulin sensitivity
(16). These results indicate that inflammatory mediators regulate
anterior pituitary cell function through the immune-endocrine axis,
and that stem/progenitor cells of the anterior pituitary gland also
have a role as immune-endocrine mediators. However, little is
known about the population and localization of immune-endocrine
mediator cells in the anterior pituitary gland.
We have established bovine anterior pituitary progenitor cell
line (BAPC)3-1 (13). BAPC-1 express stem/progenitor cell-related
genes, such as Nestin, Nanog, Oct-4, Ptch1, Notch1, Hes1, Lrp,
Fzd4, Lhx3, Pitx1, and pit-1, whereas they also express several
cytokine mRNAs, including IL-1, IL-6, IL-7, IL-12, IL-15, and
IL-18. In addition, stimulation with IL-18 causes the induction of
IL-1 and IL-8 mRNA expression in BAPC-1. Although IL-18 is
expressed in somatotrophs as it is in the cells of Rathke’s pouch in
the bovine anterior pituitary gland (4), BAPC-1 is not immunore-
active for growth hormone. These findings suggest that BAPC-1
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may be a pituitary progenitor cell and act as an immune-endo-
crine mediator through cytokine expression.
To localize the BAPC-1 cell type in the pituitary gland, and
thereby possibly identify pituitary progenitor cells, we immunized
BALB/c mice with BAPC-1 and produced mAbs. After selection
on the basis of reactivity against the membrane protein of BAPC-1,
we established a mAb that we named 12B. mAb 12B recognizes
the 4Ig-B7-H3 molecule, which is a costimulatory molecule and a
negative regulator in T cell activation (17). This mAb also reacted
to cells in the marginal cell layer around Rathke’s pouch. In ad-
dition, we observed that BAPC-1 expressed MHC class II and had
a phagocytic activity. These data indicate that pituitary progenitor
cells may be constituent cells of the marginal cell layer, suggesting




Thirteen Holstein cattle (males and females, up to 36 mo of age) were used.
The cattle were housed in pens under natural lighting conditions. Addi-
tionally, 12 BALB/c mice (7 wk old, male) were purchased from Japan
SLC. These animals were handled in accordance with the guidelines of the
Administrative Panel on Laboratory Animal Care of Tohoku University.
Development of anti-BAPC-1 mAb
BAPC-1 were maintained in DMEM (Life Technologies) supplemented
with 10% FBS (10% FBS-DMEM). The 12B mAb (mAb, IgG2b) was
obtained by immunizing three mice with BAPC-1. Briefly, mice were im-
munized i.p. with 1  107 BAPC-1 cells. After 14 days, mice were i.v.
immunized again and sacrificed 5 days later. The splenocytes were fused
with SP2/0-ag14-K13 mouse myeloma cells in the presence of 50% (w/v)
polyethylene glycol (4000). Fused spleen-myeloma cells were selected by
culturing in HAT medium (RPMI 1640 medium containing 2 mM glu-
tamine, 0.2% glucose, 1 mM pyruvic acid, 10% FBS, 100 M hypoxan-
thine, 0.4 M aminopterin, and 16 M thymidine). The hybridoma cells
were screened for anti-BAPC-1 Ab production by flow cytometry, as de-
scribed below, and cloned by limiting dilution. mAb was produced in as-
cetic fluid of BALB/c mice primed with pristine, and the mAb was purified
by a MABTrap kit (Amersham Biosciences). The subclass and type of
mAb were determined by a mouse mAb isotyping kit (Dainippon Sumi-
tomo Pharma).
Flow cytometry
BAPC-1 cells were treated with a sucrose/EDTA buffer (pH 7.5; 0.45 M
sucrose, 0.36% EDTA, 0.1% BSA in PBS) for 4 min, detached by 0.04%
trypsin in PBS, and resuspended in PBS. Approximately 1  106 BAPC-1
cells were incubated with 10 g/ml 12B mAb and anti-CD45 (50;
VMRD) for 30 min at 4°C, washed three times, and then resuspended in
PBS. The cells were incubated with FITC-labeled goat anti-mouse IgG
(25; Southern Biotechnology Associates), washed three times, and re-
suspended in FACS Flow diluent (BD Immunocytometry Systems) for
flow cytometric analysis.
Bovine PBMC were obtained from the jugular veins of three 7- to 13-
wk-old calves and three 20- to 60-mo-old Holstein cows and adjusted to
1 107 cells/ml, as previously described (18). PBMC were incubated with
12B mAb and MM1A (CD3, IgG1), CACT138A (CD4, IgG1), BAQ111A
(CD8, IgM), CACT61A (TCR-N12, IgM), or B7A1 (WC1-N1, IgM) mAb
for 30 min at 4°C. These Abs were purchased from VMRD and used at a
1/50 dilution. Subsequently, PBMC were incubated with FITC-labeled
goat anti-mouse IgG2b Ab (25; Southern Biotechnology Associates) and
PerCP-labeled rat anti-mouse IgG1 (5; BD Biosciences) or PE-labeled
goat anti-mouse IgM (25; Southern Biotechnology Associates) Ab. All
data that were acquired by FACSCalibur (BD Biosciences) were analyzed
by CellQuest software (BD Biosciences).
Immunohistochemistry
The anterior pituitary glands of four 13-wk-old calves and three 20- to
36-mo-old steers were immersed in Zamboni’s fixative overnight at 4°C.
The tissues were then paraffinized and cut to 2 m thickness. The depar-
affinized sections were washed three times with PBS for 5 min and incu-
bated in 1.5% normal goat serum for blocking. The sections were incubated
with 12B (10 g/ml), TH14B (MHC class II, VMRD; 100), or mouse
anti-human IL-18 (5 g/ml) mAb overnight at 4°C. For the identification
of MHC class II-immunoreactive cells, sections were incubated with Da-
koCytomation Target Retrieval Solution High pH (DakoCytomation) for 5
min at 121°C before blocking as an Ag retrieval technique. After several
washings, the sections were then incubated with Simplestain MAX-PO (M)
(Nichirei) as a secondary Ab for 1 h. After washing with PBS, the sections
were visualized with 0.025% 3.3-diaminobenzidine and 0.01% H2O2 in
0.05 M Tris buffer (pH 7.6) and counterstained with Mayer’s hematoxylin.
To determine the colocalization of the 12B and MHC class II, or 12B and
IL-18 immunoreactive cells, mirror section technique was performed, as
previously described (4).
Immunocytochemistry
BAPC-1 were seeded into Sonicseal slides (Nunc) and cultured to 80%
confluence. Cells were fixed with 4% paraformaldehyde for 10 min at 4°C,
permeabilized with acetone for 10 min at 20°C, and then washed five
times with PBS. The chamber slides were incubated in PBS containing
1.5% normal goat serum for 20 min and then treated with primary Abs in
PBS overnight at 4°C. After washing, the chamber slides were incubated
with FITC-conjugated goat anti-mouse IgG Ab (400; Sigma-Aldrich) for
1 h and then counterstained with ToPro3 (Molecular Probes) for 10 min.
These slides were observed using a confocal laser microscope (MRC-1024;
Bio-Rad).
Identification of 12B Ag molecule
BAPC-1 were detached and resuspended in PBS. Approximately 5  106
BAPC-1 cells were incubated with 3 g/ml 12B mAb in PBS for 30 min
at 4°C. After several washes with PBS, the cells were lysed in 0.5% Triton
X-100 buffer and subsequently centrifuged at 9200  g for 10 min at 4°C.
The supernatant was immunoprecipitated using MACS protein G (Milte-
nyi Biotec), according to the manufacturer’s instructions. The sample was
separated by SDS-PAGE and stained with SimplyBlue SafeStain (Invitro-
gen Life Technologies). The 12B-reactive protein at 75 kDa was cut and
then identified by liquid chromatography/tandem mass spectrometry (LC-
MS/MS) analysis (APRO Life Science Institute).
Western blotting
The 12B-reactive protein was prepared by immunoprecipitation, as de-
scribed above, separated by SDS-PAGE, and electrotransferred onto Im-
mobilon-P membrane (Millipore). After the electrotransfer, the membrane
was blocked with 0.05% Tween 20/PBS (PBS-T) containing 1% BSA and
1.5% normal horse serum overnight at 4°C. After three washings with
PBS-T for 10 min, the membrane was treated with 1 g/ml 12B mAb or
goat anti-human B7-H3 Ab (R&D Systems). The membrane was washed
Table I. Primer sequences used in this study
Targets Forward Primer Reverse Primer Annealing Temperature Product Size (bp)
4Ig-B7-H3 1 CTGCCTCTCGAGAAGATGCT AACCTGGACTTCCACTGCAC 55°C 765
4Ig-B7-H3 2 GTGCAGTGGAAGTCCAGGTT TGATCTTTCTCCAGCACACG 55°C 744
4Ig-B7-H3 3 GGGCGCTAATGGTACCTACA CCTCGCGGTCAGACTATTTC 55°C 324
Nanog ACCCGGAGATCTTCACCTTT TTGATGTCCTGGGACTCCTC 55°C 527
Oct-4 GGTTCTCTTTGGAAAGGTGTTC ACACTCGGACCACGTCTTTC 55°C 314
Fzd4 TCACTGTGCTCACCTTCCTG CTTCGTCCCATCCTTTTGAA 55°C 572
B7-1 GAACCGCACCATCACTGACA TAATGGTCCAGGTCAGGTGC 56°C 485
B7-2 GACCTTGAGACTCCACAACG GTAGAGCTGCAATCCAGAGG 59°C 490
G3PDH ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA 55°C 452
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and incubated with a biotinylated goat anti-mouse IgG Ab or rabbit
anti-goat IgG Ab (Vector Laboratories) containing 1% FBS for 2 h. After
five washes, the membrane was treated with ABC-PO kit (Vector Labo-
ratories) for 1 h. Immunoreactive proteins were visualized using a diami-
nobenzidine detection kit (Vector Laboratories).
Partial DNA sequence of bovine 4Ig-B7-H3 and gene
expression analysis by RT-PCR
Total RNA from BAPC-1 was isolated using TRIzol (Invitrogen Life Tech-
nologies) and reverse transcribed for 60 min at 50°C using Superscript III
(Invitrogen Life Technologies). Reverse-transcription reaction products
were amplified with specific primer pairs (Table I) designed from the pre-
dicted sequence (accession XM 864408). The amplification was performed
in 1 cycle for 5 min at 94°C, 35 cycles of denaturation for 1 min at 94°C,
annealing for 1 min at 59°C, and extension for 1 min at 72°C. Each single
band was purified from the gel and sequenced (accession AB271019).
To determine the expression of 4Ig-B7-H3, total RNA from the anterior
pituitary gland, hypothalamus, and PBMC from a 13-wk-old calf were
extracted and subjected to RT-PCR, as described above. Reverse-transcrip-
tion reaction products were amplified with the primer pairs for 4Ig-B7-H3
3. As the housekeeping gene, PCR was also performed with G3PDH prim-
ers. The amplification was performed in 1 cycle for 5 min at 94°C, 20
cycles of denaturation for 1 min at 94°C, annealing for 1 min at 55°C, and
extension for 1 min at 72°C. Each of the specific primer pairs is summa-
rized in Table I.
Phagocytosis assay
BAPC-1 were seeded into 4-well chamber slides (Nunc) and cultured to
80% confluence. Yellow-green fluorescent microspheres (1 107 beads,
diameter 1 m; Molecular Probes) were added to the cells and incubated
for 1 or 12 h. After incubation, the cells were washed with PBS and fixed
with 4% paraformaldehyde in PBS for 30 min at 4°C. The cells were
counterstained with ToPro3 for 10 min and were observed by the confocal
laser microscope.
Separation and phenotypic analysis of 12B-positive cells from
PBMC
Freshly isolated PBMC were firstly incubated with 12B mAb for 30 min at
4°C, and washed three times with PBS containing 0.5% BSA and 2 mM
EDTA. These cells were then incubated with 20 ml of rat anti-mouse IgG
(2a 2b) Ab conjugated with magnetic beads (Miltenyi Biotec) for 30 min
at 4°C. The magnetic bead-labeled PBMC were positively separated using
Auto MACS magnetic columns (Miltenyi Biotec). The cells passing
through the magnetic column were collected as 12B-negative cells. The
purity and phenotypes of the collected cells were analyzed by FACS anal-
ysis using mAbs, as described above, and RT-PCR. Each of the specific
primer pairs is summarized in Table I (19, 20). Nanog and Fzd4 primer
pairs were designed from predicted sequences or from other species, and
the PCR products were sequenced (AB257753).
Effect of BAPC-1 and 12B mAb on CD25 expression in PBMC
BAPC-1 cells (1  104 cells/cm2) were seeded into 12-well plates (Nunc)
and cultured to 80% confluence. Bovine PBMC were added to 12-well
plates (1  104 cells/well) and cultured with or without the BAPC-1. The
4Ig-B7-H3 was neutralized by adding 12B mAb (10 g/ml) to the wells.
After 5 days, PBMC were harvested and analyzed for the expression of
CD25 (CACT116A, 50; VMRD) by FACS analysis as the activation
marker (21, 22).
Results
Isolation of mAb 12B
To identify cell surface markers expressed in BAPC-1 and the
localization of this cell type in the anterior pituitary gland, mice
were immunized twice with BAPC-1. Four hybridoma clones
were identified as producing mAbs reacting to BAPC-1. One
clone termed 12B (IgG2b) reacted strongly with BAPC-1 and
was used for further studies (Fig. 1A). The 12B mAb was also
used for the immunocytochemistry and immunohistochemistry.
The cell surface of BAPC-1 was stained with 12B mAb (Fig.
1B). In the bovine anterior pituitary gland, 12B-immunoreactive
cells were localized around Rathke’s pouch (Fig. 1C). No stain-
ing was observed in tissue sections treated with an unrelated
mouse IgG primary Ab (negative control; data not shown).
Identification and LC-MS/MS analysis of 12B Ag
To identify the 12B Ag, immunoprecipitation was performed using
BAPC-1 incubated with 12B mAb (Fig. 2). A band at 75 kDa
FIGURE 1. Reactivity of mAb 12B in BAPC-1 and anterior pituitary tissue. BAPC-1 were screened by flow cytometry for reactivity to the 12B Ab (A).
The y-axis and x-axis show cell counts and staining intensity, respectively. The gray line was the negative control stained only with the secondary Ab.
BAPC-1 were cultured to 80% confluence and stained with 12B (B). The immunohistochemical expression of the 12B Ab in a paraffin-embedded bovine
anterior pituitary gland (C). Scale bars  50 m (B) and 10 m (C).
FIGURE 2. Identification of 12B-reactive molecule. BAPC-1 cell lysate
was separated by SDS-PAGE and subjected to Western blot analysis (lanes
1 and 2). The 12B mAb-immunoprecipitated BAPC-1 sample was sepa-
rated by SDS-PAGE (lane 3) and transferred to a polyvinylidene difluoride
membrane (lanes 4 and 5). Western blotting analysis showed that 12B mAb
recognizes a protein of 75 kDa. Lane 1, 12B mAb. Lane 2, Mouse control
IgG. Lane 3, CBB staining. Lane 4, Goat anti-human B7-H3. Lane 5,
Normal goat serum.
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was detected by Western blotting, extracted from the staining gel,
and subjected to LC-MS/MS analysis (lanes 1 and 3 in Fig. 2). The
LC-MS/MS results from the database search are summarized in
Table II. The database search identified three peptides, as follows:
bovine CD276 Ag (4Ig-B7-H3), bovine lysozyme, and human se-
cretoglobin 2A. Four different peptides allowed the identification
of the 12B Ag molecule. Each peptide corresponded to a trans-
membrane protein termed 4Ig-B7-H3 (23) (gray boxes in Fig. 3).
When Western blotting was performed using an anti-human
B7-H3 Ab, the Ab also detected a specific band at 75 kDa as for
the 12B mAb (lane 4 in Fig. 2). Previous reports have shown that
B7-H3 has two isoforms generated by alternative splicing. These
are 2Ig- and 4Ig-B7-H3. The 4Ig-B7-H3 is expressed in the hu-
man, but 2Ig-B7-H3 is not (23, 24). We were not able to identify
any band corresponding with 2Ig-B7-H3 in the 12B-immunopre-
cipitated sample, and nothing was identified in cells treated with
normal mouse IgG as the primary Ab (negative control) (lanes 2
and 5 in Fig. 2).
Identification of bovine 4Ig-B7-H3 partial mRNA and its
expression
Although there are no reports of the sequence of bovine 4Ig-B7-H3
mRNA, the sequences of the peptide immunoprecipitated by 12B
mAb were matched to a predicted sequence derived from bovine
annotated genomic sequence (Fig. 3). The mRNA expressed in
BAPC-1 was sequenced using specific primer pairs designed from
the predicted sequence. PCR products were determined (accession
AB271019) and predicted for a 528 aa sequence (Fig. 3). There
were three differences in the nucleotide sequence between the pre-
dicted sequence and PCR-determined sequence. The determined
sequence demonstrated extensive homology (93.9%) with human
4Ig-B7-H3. The peptide sequences identified by LC-MS/MS anal-
ysis were also matched with the determined sequence (gray boxes
in Fig. 3).
FIGURE 3. Position of identified peptides in the bovine 4Ig-B7-H3 amino acid sequence. The 75-kDa band immunoprecipitated by the 12B mAb was
cut from the CBB-stained gel. Four peptide sequences were identified by LC-MS/MS analysis and matched to human 4Ig-B7-H3 amino acid sequence (gray
boxes). The amino acid sequence of bovine 4Ig-B7-H3 was determined by specific primer pairs designed from the predicted sequence, and was the same
as the four portions of the immunoprecipitated peptide sequences (gray boxes). Bovine predicted: predicted 4Ig-B7-H3 sequence that is derived from an
annotated genomic sequence (XP869501). Bovine sequenced: the determined sequence from BAPC-1 cDNA (accession AB271019). Human: the registered
sequence of human mRNA (NP 001019907).
Table II. Predicted peptides by LC-MS/MS
Peptides Organisms Accession No. Total Score
CD276 (4Ig-B7-H3) Bovine 869501 247
Lysozyme Bovine 841217 52
Secretoglobin, 2A Human 4505171 52
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To investigate 4Ig-B7-H3 expression in a 13-wk-old calf, RT-
PCR was performed using total RNA extracted from PBMC, the
hypothalamus, and the anterior pituitary gland (Fig. 4A). The 4Ig-
B7-H3 mRNA was expressed in PBMC and in the anterior pitu-
itary, but only to a very small extent in the hypothalamus. BAPC-1
expressed 4Ig-B7-H3 mRNA, but not a hematopoietic lineage
marker CD45 (Fig. 4, B and C). A specific band was also detected
using other primer pairs used for the sequencing (data not shown).
Identification of 12B-reactive cells in PBMC
Previous studies have shown that immature and mature dendritic
cells are brightly stained by anti-4Ig-B7-H3 Abs in humans, and
that normal lymphocytes and the cultured NK, B, and T cell lines
are not reactive with this Ab (23, 25). Fig. 4 shows that the ex-
pression of 4Ig-B7-H3 mRNA was detected in bovine PBMC.
Therefore, flow cytometric analysis was performed to identify
12B-reactive cells. The 12B-reactive cells accounted for 16.4%
of PBMC from the 13-wk-old calves. However, PBMC from the
20-mo-old cows did not react with the 12B mAb (Fig. 5, A and B).
Following this, we assessed the surface distribution of the 12B-
reactive molecules on PBMC from the 13-wk-old calves. Thirty
percent of CD3 cells (T cells) reacted with the 12B mAb, which
accounted for 14.2% of the PBMC (Fig. 5C). However, the 12B
mAb did not react with CD4 and CD8 cells (Fig. 5, D and E).
Fifty percent of TCR1 ( T) cells were positive for 12B mAb
(Fig. 5F). In the 12B-reactive  T cells, almost all WC1 cells
were stained with12B mAb (Fig. 5G). These results indicate that
12B-reactive cells in PBMC are WC1  T cells.
Localization of 12B Ag in the pituitary gland
The BAPC-1 cells were established from the anterior pituitary
gland of a 7-wk-old calf (13). Because we were not clear of the
origins of BAPC-1, we performed immunohistochemistry using
the 12B mAb on the anterior pituitary glands of 13-wk-old calves
and 20-mo-old adult steers (Fig. 6). In the calves, 12B-reactive
cells were localized around Rathke’s pouch in the anterior lobe
(Fig. 6A). Stained cells were also localized to the same area in the
adult steers; however, the number of positive cells in adult steers
was lower than that of the calves (Fig. 6E). The 12B-reactive cells
were observed around the pars tuberalis in the anterior lobe of both
the young and adult animals, which adhered closely to median
eminence and had blood supply via the primary portal plexus (Fig.
6, B and F). Some 12B-reactive cells were observed in the inter-
mediate lobe and existed around Rathke’s pouch sparsely in both
the young and adult animals (Fig. 6, C and G). In the neural lobe
of both samples, some pituicytes were immunoreactive for the 12B
mAb, and the reactivity of 12B mAb in the intermediate and neural
lobe of the adult steers was stronger than in calves (Fig. 6, D and
FIGURE 4. Expression of 4Ig-B7-H3 and CD45 in BAPC-1 and bovine
cells. Total RNA was isolated from bovine PBMC, the anterior pituitary
gland, the hypothalamus, and BAPC-1, and subjected to RT-PCR (A) using
the specific primer pair for 4Ig-B7-H3 3 in Table I. The products marked
with an arrow result from the RT-PCR. The housekeeping gene, G3PDH,
served as the internal standard. FACS analysis was used to determine the
expression of CD45 in BAPC-1 (B) and PBMC (C). The gray-filled his-
tograms are the negative controls that were stained with a secondary Ab
only.
FIGURE 5. Flow cytometric analysis of 4Ig-B7-H3-positive cells in bo-
vine PBMC. PBMC from a 13-wk-old calf (A) and a 5-year-old cow (B)
were analyzed using the 12B mAb. The gray-filled histograms are negative
controls that were stained with only a secondary Ab. The PBMC from the
13-wk-old calf were also analyzed with 12B and CD3 (C), CD4 (D), CD8
(E), TCR1 (F), or WC-1 (G) Abs and detected by dual-color flow cyto-
metric analysis. The percentage of cells staining positively is indicated in
each box.
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H). In addition, the cells in the pouch and pars tuberalis showed the
same reactivity in both the calves and the adult steers.
Colocalization of 12B and MHC class II Ags in the anterior
pituitary gland
B7-H3 is known to be a costimulatory molecule in APCs, which
also express MHC class II Ag (26). Immunocytochemistry shows
that BAPC-1 also expressed MHC class II (Fig. 7A). In the anterior
pituitary gland, some 12B-positive cells weakly expressed MHC
class II (arrows in Fig. 7, B and C). Cells that strongly expressed
MHC class II were negative for 12B mAb (arrowheads in Fig. 7,
B and C). IL-18-reactive cells in the layer of Rathke’s pouch also
reacted for 12B mAb; however, IL-18-reactive cells in the hor-
monal cells were not reactive for 12B mAb in the other regions
(arrows in Fig. 7, D and E).
Phagocytosis assay of BAPC-1
To analyze phagocytic activity of BAPC-1, the cells were incu-
bated with yellow-green fluorescent microspheres for 1 and 12 h.
BAPC-1 were able to incorporate some microspheres into the cy-
tosol after 1 h, and numerous microspheres were phagocytosed by
BAPC-1 after 12 h (Fig. 8, A and B). BAPC-1 also phagocytosed
FITC-labeled Escherichia coli after a 12-h incubation (data not
shown). The X-Z section revealed that microspheres were incor-
porated into the cytoplasm of BAPC-1 and detected around their
nuclei (Fig. 8, C and D).
Expression of B7 family and pluripotency-related genes in
BAPC-1
The 12B-positive and 12B-negative cells were collected from
PBMC using MACS magnetic columns and subjected to FACS
analysis to evaluate the phenotype of the 12B-positive cells. The
purity of the 12B-positive cells was 93.2%, and their persistence in
12B-negative cells was 19.6% (Fig. 9, A and G). The 12B-positive
cells were largely composed of CD3 T cells (84.5%), and WC1
 T cells accounted for50% of these. However, the populations
of CD4 and CD8 cells in these were quite low (Fig. 9, B–F). In
contrast, WC1 cells and  T cells accounted for 2.8 and
13.5% of the 12B-negative cells, respectively (Fig. 9, K and L).
A B C D
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FIGURE 6. Localization of 4Ig-B7-
H3-expressing cells in bovine pituitary
gland. Immunostaining was performed
with 12B mAb on pituitary glands from
13-wk-old (A–D) and 19-mo-old (E–H)
cattle. RP: anterior lobe section around
Rathke’s pouch. PT: anterior lobe sec-
tion around the pars tuberalis. IL: inter-
mediate lobe section around Rathke’s





FIGURE 7. Localization of 12B and MHC class II-expressing cells in
the anterior pituitary gland. BAPC-1 were stained with MHC class II Ab
(A). A couple of mirror sections were stained with Abs against 12B (B) or
MHC class II (C), and 12B (D) or IL-18 (E) in the anterior pituitary gland
of a 13-wk-old calf. Arrows show the colocalized cells with 12B and MHC
class II, or 12B and IL-18. Arrowheads show MHC class II-positive cells






FIGURE 8. Phagocytosis activity of BAPC-1. BAPC-1 were incubated
with microspheres (green) for 1 (A and C) or 12 h (B and D). The cells were
counterstained with ToPro3 (red). X-Z: X-Z plane pictures from consec-
utive z-sections and three-dimensional reconstruction. Scale bars 
10 m.
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Next, we investigated the expression of the B7 family and plu-
ripotency-related genes in BAPC-1 and 12B-positive and 12B-
negative PBMC (Fig. 10). The 12B-positive and 12B-negative
PBMC expressed the B7 family of genes, a pluripotent cell marker
Oct-4 (20), and a canonical Wnt signal receptor Fzd4, but did not
express Nonag, which is also known as a key marker of stem cells
(27). In contrast, BAPC-1 marginally expressed B7-1, but not
B7-2. Of the pluripotency-related genes, BAPC-1 expressed Oct-4
to a lower extent than the PBMC, but the mRNA expression of
Nanog was detected in BAPC-1. Although BAPC-1 expressed
the 12B Ag (4Ig-B7-H3), there were quite large differences in
the expression of phenotypic markers between BAPC-1 and
12B-positive PBMC.
Effects of BAPC-1 and 12B mAb on expression of CD25 in
PBMC
The 4Ig-B7-H3 molecule recognized by 12B mAb is known to be
a costimulatory molecule and a negative regulator in T cell acti-
vation (20, 21). However, it is not clear how the interaction be-
tween PBMC, cells like BAPC-1, and the 4Ig-B7-H3 molecule
affects cell function in the marginal cell layer of Rathke’s pouch in
the anterior pituitary gland. We cocultured PBMC and BAPC-1
with or without 12B mAb and measured the expression of acti-
vated T cell marker CD25 by FACS analysis (Fig. 11). After 5days
of culture, CD25-positive cells were not observed in the single
culture of PBMC with or without 12B mAb. In contrast, CD25-
positive cells accounted for 34.8% of the cells in the coculture.
FIGURE 9. Identification of 12B-positive cells in PBMC. PBMC were
treated with 12B mAb and collected by the positive or negative selection
using Auto MACS magnetic columns. The purity was confirmed using
anti-mouse IgG2b (A and B, solid lines). The 12B-positive (12B) and
12B-negative (12B) cells were subjected to FACS analysis using anti-
WC1 (C and D), CD3 (E and F), CD4 (G and H), CD8 (I and J), and TCR1
(K and L) Abs. The gray-filled histograms are the negative controls that







FIGURE 10. Expressions of the B7 family and pluripotency-related
genes in BAPC-1. Cells were separated from PBMC by 12B-positive or
12B-negative selection using Auto MACS magnetic columns. Total RNA
was isolated from PBMC and BAPC-1. The cDNA was subjected to PCR
using the specific primer pair of the indicated genes in Table I. G3PDH was
used as the control.
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In addition, supplementation with 12B mAb significantly in-
creased the population of CD25-positive cells to 44.0% in the co-
culture. No morphological changes were observed in BAPC-1 after
5 days of coculture (data not shown). These data suggest that
BAPC-1-like cells and the 4Ig-B7-H3 molecule may regulate the
cell function of PBMC in the layer of Rathke’s pouch in the pi-
tuitary gland.
Discussion
In this study, we revealed that the 12B mAb, raised against
BAPC-1, recognized the 4Ig-B7-H3 molecule, and that 12B-reac-
tive cells were localized in the layer of Rathke’s pouch in the
pituitary gland. Rathke’s pouch has been proposed to embody a
stem/progenitor cell compartment. BAPC-1 expresses stem/pro-
genitor cell-associated molecules and factors (13); however, it is
not yet clear from what kind of cell BAPC-1 originates. Consid-
ering the immunohistochemical data on the expressions of MHC
class II and IL-18, BAPC-1 may originate from a stem/progenitor
cell in the layer of Rathke’s pouch in the anterior pituitary gland.
The 4Ig-B7-H3 is a member of the B7 family of cell surface mark-
ers (23, 24). In both the human and mouse, B7-H3 binds to an
unidentified receptor expressed on activated T cells and NK cells,
and exerts an inhibitory function on their cell-mediated responses
(17, 25, 28). It is known that B7-H3 mRNA is expressed in many
tissues and organs, such as skeletal muscle, kidney, pancreas,
heart, and brain, suggesting that it may also play a number of roles
outside of the immune system (24, 26).
Cattle have large numbers of circulating  T cells, of which the
majority express a WC1 molecule (29). The WC1 molecule is
expressed in ruminants and pigs, but not in humans and mice (30,
31). WC1  T cells are decreased in number in older cattle (32).
WC1  T cells can form up to 35% of the PBLs of yearlings and
5–10% in adults. WC1  T cells in the young bovine PBMC
expressed a 4Ig-B7-H3 molecule, but little or no 4Ig-B7-H3-im-
munoreactive cells could be found in PBMC of adults (Fig. 5). It
is also known that cultured WC1  T cells can act as APCs for
 T cells (33). In contrast, WC1  T cells inhibit the prolif-
eration of CD4 T cells in response to Mycobacterium avium
subsp. paratuberculosis Ags (34). WC1  T cells represented
the bulk of the population of 12B-positive cells in the PBMC, and
12B-positive cells clearly expressed the Oct-4 mRNA (Fig. 10).
Because Oct-4 plays an essential role to prevent embryonic stem
cells from differentiating (27), WC1  T cells in PBMC may
have primitive phenotypes.
Although BAPC-1 marginally expressed B7-1, but not B7-2, the
expressions of these mRNA were observed in 12B-positive cells
(WC1  T cells) of PBMC (Fig. 10). A recent study has shown
that B7-1 and B7-2 have significant implications for the manipu-
lation of immune responses and tolerance related with regulatory T
cells (35). In addition, TLR4 ligation enhances the expression of
B7-1 and decreases B7-2 on human oral mucosal Langerhans cells
with tolerogenic properties, and contributes to the tolerogenic state
(36). These reports suggest that bovine WC1  T cells of PBMC
may have some tolerogenic functions.
Given that 4Ig-B7-H3-positive cells in the layer of Rathke’s
pouch were fewer in adult cattle than in young animals in the
present experiments (Fig. 6), there may be some differences in
cellular immunomodulatory functions in the layer of Rathke’s
pouch between young and adult animals. In the rat anterior pitu-
itary gland, Nestin-immunoreactive cells in the layer of Rathke’s
pouch are also fewer in the adult than in the young rat (11). These
results indicate that there may be fewer progenitor cells in the layer
in adult animals than in young animals.
The 4Ig-B7-H3 molecule is a member of the B7 family, which
is critical for the regulation of cell-mediated immune responses
(37). B7-1 and B7-2 are other molecules of the B7 family and can
activate T cells by cross-presentation (38). BAPC-1 also express
MHC class II and have phagocytic activity, but do not express the
mRNA of B7-2 (Fig. 10). Human mesenchymal stem cells also
express MHC class II, but do not express B7-1 and B7-2, and
display the immunomodulatory function (39, 40). BAPC-1 had the
ability to promote CD25 expression in PBMC after 5 days of co-
culture, and blocking 4Ig-B7-H3  12B mAb enhances their ex-
pression of CD25 (Fig. 11). These results suggest that BAPC-1
may regulate the function of T cells in a similar manner to human
mesenchymal stem cells. Our immunohistochemical data also
show the colocalization of IL-18 and the 4Ig-B7-H3 molecule in
the layer of Rathke’s pouch. In contrast, the immunoreactivity of
MHC class II in the cells of Rathke’s pouch seemed weak and
demonstrated an intracellular localization in the cytoplasm. These
results also suggest that the stem/progenitor cells in the layer of
FIGURE 11. Effects of BAPC-1 and 12B mAb on the expression of
CD25 in PBMC. BAPC-1 were cultured to 80% confluence in 12-well
plates. PBMC were added to the wells and cocultured with or without
BAPC-1 and/or 12BmAb. After 5 days, the expression of CD25 in PBMC
was measured by FACS analysis. The gray-filled histograms are negative
controls that were stained with the secondary Ab only. The data are ex-
pressed as means  SEM (n  3). Values with different letters are statis-
tically different (p  0.01). Results are representative of three identical
experiments.
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Rathke’s pouch may have an immunomodulatory activity, but not
the typical ability of Ag presentation.
In conclusion, we have succeeded in identifying the costimula-
tory molecule 4Ig-B7-H3 in bovine anterior pituitary progenitor
cells in the layer of Rathke’s pouch. We have established BAPC-1,
which is indicated to originate from these progenitor cells, and
expresses the same molecule. We believe the progenitor cells ex-
pressing the 4Ig-B7-H3 molecule may play a critical role in ante-
rior pituitary functions, such as in the immunoendocrine network.
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